>>On the Market

Healthcare Professionals: Please visit the Aggrastat product website.

>>In Development

Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
Read more..

>>Latest News

December 18, 2014
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue Read more

November 5, 2014
Dr. Albert Friesen To File Early Warning Report Read more

October 16, 2014
Medicure Reports Financial Results For The First Quarter Fiscal 2015 Read more

Sign up to receive email updates such as Press Release nofications and other company news.

>>Clinical Trials

SAVI-PCI
Read more on clinicaltrials.gov

TEND TD
Read more on clinicaltrials.gov

>>A Heart for Life

Medicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human
therapeutics. Find out more.